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Abstract
Peripheral CD4CD8 double positive (DP) T cells have been reported to play a role in several autoimmune diseases, virus
infections and cancer. In rheumatoid arthritis (RA), both CD4 and CD8 single positive (SP) T cells are known to be involved in
the pathogenesis, but the role of peripheral CD4CD8 DP T cells has not been investigated in detail. Anti cyclic citrullinated
antibodies (ACPA) positive and ACPA negative RA patients, patients with systemic lupus erythematodes (SLE) and age
matched healthy donors (HD) were enrolled in the analysis. The frequencies and phenotype of DP T cells in PBMC were
investigated. In addition, DP T cells were quantified in biopsies from rheumatoid synovium. After in vitro restimulation, the
cytokine production of DP T cells was investigated in cultures of PBMC. CMV specific cytokine secretion as well as
proliferation was analyzed following antigen specific restimulation after an appropriate culture duration. DP T cells were
found more frequently in RA patients than in healthy controls or patients with SLE. These DP T cells express ab TCRs, are of a
memory phenotype and share features of both CD4 as well as CD8 SP T cells. Importantly, DP T cells were found to also be
present in the rheumatoid synovium. Further characterization of DP T cells from RA patients revealed increased production
of IL-21 and IL-4, implying a possible role as T helper cells. In addition, DP T cells in RA seem to contribute to the
inflammatory process, because they produce significantly more IFNc than counterparts from HD and are increased in CMV+
RA patients. Given their capacity to produce a variety of cytokines (IL4, IL21 and IFNc), their association with ACPA positive
RA and their presence in the synovium, we suggest an important role of double positive T cells in the pathogenesis of
rheumatoid arthritis.
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Materials and Methods
Patients and Healthy Individuals
A total of 59 RA patients according to the 2010 EULAR/ACR
criteria (female: 46, male: 13, mean age 59.4 years, range 34–79
years) were recruited, among them 39 ACPA+ and 20 ACPA2
patients. 39% of the RA patients were treated with biologicals in
combination with conventional standard therapy. Sex and age
distribution in ACPA+ versus ACPA2 patients was similar. In
addition, 8 SLE patients (all female, mean age 44.3 years, range
21–54 years) were included. Blood of 36 HD (female: 21, male: 15,
mean age of 57.1 years, range 25–71 years) who never had
evidence of a chronic inflammatory disorder were recruited as
controls. The 4 RA patients undergoing knee surgery (2 male, 2
female) were all ACPA+.
Ethics Statement
Written consents were obtained from all patients and healthy
donors. The local ethics committee of the University of Leipzig
approved the study.
Antibodies and Reagents
RPMI 1640 was from Lifetechnologies. X-Vivo15 media was
supplied by Lonza. aCD3, aCD4, aCD8 (recognizing the a chain),
aCD28, aCD45RO, aCD56, aCCR7, a-IL17, aTCRa24-Ja18
(clone: 6B11), cytokine secretion assays for IFNc and IL-4, a-
fibroblast microbeads and Cytostim were purchased from
Miltenyi. Collagenase, Hyaluronidase and DNAse were all from
Sigma-Aldrich. aCD45 and aCD38 were from Immunotools.
CFDA-SE was purchased from Molecular Probes/Invitrogen.
Intra staining Kit, aCD16, aCD8b and aCD3 were from Beckton
Dickinson. aCXCR5 was supplied by R&D Systems and aIL21
was from ebioscience. The Beta Mark TCRVb Repertoire Kit was
supplied by Beckman Coulter. The antibodies were used in
different conjugates of FITC, PE, PerCp, APC, APC-Vio770 and
PE-Cy7.
PBMC Generation and FACS Analysis ex vivo
PBMCs were isolated from EDTA whole blood or buffy coats.
Plasma was always discarded from whole blood samples prior to
Ficoll-gradient for PBMCs isolation. Subsequently a erythrocyte
lysis step with lysis-buffer was applied. Cells were stained with
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different antibodies and kept on ice throughout the assay. Live Cell
analysis (use of PI) with doublet exclusion (LSR II) were performed
on a FACS Calibur TM or a LSR II (both Beckton Dickinson)
using Cellquest, FACS DIVA and FlowJo software.
CMV Specific Cytokine Production and Proliferation
These assays were performed as described recently. [1] In brief,
16106 PBMC were CFDA-SE labeled and cultured for 7 days
(proliferation) or left unlabeled and cultured for 4 hrs (26106,
IFNc secretion) in the presence of CMV lysate/control lysate
(Microbrix Biosystems Inc) of 3 mg/ml in 24-well plates in X-
VIVO 15 medium.
Short Term Culture and Staining for Cytokine Analysis
PBMCs were cultured in X-Vivo 15 supplemented with 1% of
each glutamin and penicillin/streptomycin in a density of 56106
for cytostim (1:50) or 36106 for PMA (20 ng/ml and Ionomycin
(0.5 mg/ml). Culture time was 4 hrs for both and Monensin
(2 mM) was added to the last 3 hrs of PMA/Ionomycin cultures.
Cytokines were either detected with cytokine secretion assays
(IFN-c and IL-4) following the manufactures protocol by Miltenyi
or by intracellular staining (IL-21 and IL-17) using an intra
staining Kit.
Tissue Digestions and Leucocyte Extraction
Synovial biopsies from RA patients undergoing surgery were
obtained and leucocyte isolation was performed as follows. Tissue
was cut into pieces and incubated with an enzyme solution
(collagenase, hyaluronidase, DNAse in RPMI) for 90 min and 37u
under constant rotation. Single cell suspension was obtained using
gauze and smooth mechanical disruption of digested tissue.
Subsequently cells were sorted for non-fibroblasts using anti-
fibroblast microbeads from Miltenyi. Non-fibroblast were used for
FACS analysis and CD45 staining was used additionally to other
antibodies in order to discriminate non-leucocytes.
Statistics
Statistical evaluation was performed using Prism version 3.0cx
software. Mann-Whitney test, unpaired student’s t-test and
correlation analysis with spearmen were applied.
Introduction
Peripheral CD4CD8 double positive (DP) T cells have first been
identified more than 20 years ago. Like their progenitors in the
thymus, they express the coreceptors CD4 and CD8 simulta-
neously, but in contrast to immature double positive thymocytes,
they show varying degrees of coreceptor expression, and display a
memory phenotype but no markers of recent thymic emigrants [2–
4]. DP T cells can be found in the blood of healthy individuals
where they account for about 1% of all T cells within PBMCs, but
are also present in the skin of melanoma patients and in systemic
sclerosis [5,6]. During the cause of severe virus infections such as
HIV and Hepatitis, increased frequency of DP T cells have been
described, which are Ag-specific and of high effector potential.
[2,7]. DP T cells can provide B cell help both by production of
appropriate cytokines and by cell contact due to their T helper like
phenotype [5,6], but they can also acquire killer like capacity [7,8].
In rheumatoid arthritis, CD4+ Th cells play a pivotal role in the
pathogenesis, as indicated by numerous genetic associations of the
disease with polymorphisms in T cell related genes as well as by
the clinical efficacy of CD28 co-stimulation [10] and CD4 co-
receptor blockade [9] [11]. The peripheral CD4+ T cell pool in
RA is characterized by several alterations including a paucity of
naı¨ve T cells and recent thymic emigrants, an increased memory
pool and a global loss of T cell receptor diversity accompanied by
large clonal expansions [12,13].
B cell autoreactivity is also essential in RA pathogenesis, as
indicated by autoantibody production and by the clinical efficacy
of B cell depletion [14]. The T cell help required for this has been
suggested to involve CD40-CD40L interactions [15], but addi-
tionally other receptors such as BAFF-R [16] have been identified
more recently. The result is the production of disease relevant
autoantibodies like anti-citrullinated peptide antibodies (ACPA),
anti-RA33, RF and others. ACPA positive RA in particular has
been associated with more severe joint destruction [1], frequent
extraarticular manifestations and enhanced subclinical artherio-
sclerosis [17].
A possible role of CD4CD8 DP T cells in the pathogenesis of
RA has not been investigated.
Here we report, that CD4CD8 double positive T cells are
expanded in the peripheral blood in ACPA+ RA and can also be
found in the rheumatoid synovium. DP T cells in RA show
features of T helper cells by the production of IL-4 and IL-21.
Interestingly, CMV+ RA patients show increased frequencies of
these cells and their number correlates positively with CMV
specific IFNc producers. In line with this, a high number of these
cells have lost the CD28 costimulator and DP T cells of RA
patients show higher amounts of IFNc producers than HD
counterparts. Our data are the first demonstrating a role for
CD4CD8 double positive T cells in RA.
Results
ACPA+ RA Patients have Increased Frequencies of
Peripheral DP T cells
Total CD4CD8 DP T cells were quantified as percentage of
total CD3+ T cells in PBMC, and three subpopulations
(CD4hiCD8lo, CD4hiCD8hi and CD4luCD8hi) according to the
level of coreceptor expression could be distinguished as shown in
figure 1A. CD4hiCD8lo DP T cells are the most prominent of the
DP cell populations and were found to be significantly more
frequent in PBMC from ACPA positive RA patients when
compared to healthy controls, SLE patients or ACPA negative
RA patients (mean%: RA ACPA+1.93, RA ACPA2 1.07, HD
1.24 and SLE 0.58, figure 1B). Total frequencies of CD4CD8 DP
T cells were also higher in ACPA positive than in ACPA negative
patients (figure 1C). The total CD4CD8 DP population will be
used in all subsequent displays throughout the manuscript, unless
otherwise stated. In the RA patient population no influence of age
on the frequency of DP T cells was discernible (figure 1 D). Such a
correlation was demonstrated for healthy individuals by others
[18] and was also found in our own data for HD. (data not shown)
A trend towards a further decrease of DP T cells in SLE patients
compared to age matched controls did not reach statistical
significance.
DP T cells in RA Belong to the Memory Pool of TCRab T
cells and Display No Marker of iNKT cells
The previously described expansion of the memory pool in RA
patients [12] was apparent in the analysis of CD4 SP T cells, 70%
of which had a central memory phenotype characterized by
expression of CD45RO and CCR7 (figure 2A). In agreement with
previous reports [2,7], the majority of CD4CD8 DP T cells was
also found to belong to the memory pool (87.9%). Analysis of
CD45RO and CCR7 expression identified 58.4% as central
memory cells (see figure 2A) and 29.5% as effector memory cells.
Double Positive T Cells in RA
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The described spectrum of memory markers on DP T cells from
RA patients did not differ from healthy controls (data not shown).
With regards to activation markers, DP T cells did not differ
from CD4 and CD8 SP cells in their expression of CD38.
Expression of the T cell activation marker HLA-DR [19],
however, was found on DP T cells more frequently than on
CD4 SP cells, but less frequently than on CD8+ SP lymphocytes
(figure 2B). In healthy donors, in contrast, HLA-DR expression on
DP T cells did not differ from that of CD4 SP T cells (data not
shown. CD56, which can also serve as activation marker for T
cells [34], was also found significantly more frequently on DP T
cells than on CD4 SP T cells (figure 2D). Other markers associated
with activation/regulation like CD69 and CTLA-4 were not
expressed on DP T cells (data not shown).
In peripheral blood from RA patients, CD4CD8 DP T cells
expressed almost exclusively (99,3%) ab T cell receptors, which
was comparable to CD4 SP T cells (99,3%, figure 2 C). DP T cells
were not ch T cells (data not shown). Distribution of ab and ch
TCR expression in the T cell subpopulations was similar in HD
(data not shown). In accordance with previous reports [35],
CD4hiCD8lo DP T cells in RA do not express ab CD8
heterodimers but aa homodimers, whereas CD8 SP cells are
almost exclusively CD8ab positive (figure 2C).
DP T cells in HD have been described to partially belong to a
population of T cells with NK phenotype, called NKT cells. [4]
Figure 1. Increased frequencies of peripheral CD4CD8 DP T cells in ACPA+ rheumatoid arthritis patients. PBMC were isolated from RA
patients (ACPA+, n = 37, ACPA2, n = 20), healthy donors (n = 36), and patients with SLE (n = 8), and FACS analyses from live cells (PI staining used for
exclusion of dead cells) were performed. Analyses for CD4CD8 double positive T cells are always pregated on CD3 positive T cells. A) Representative
FACS plot from one RA patient, showing CD4CD8 double positive T cells, R1 = CD4hiCD8lo, R2 =CD4hiCD8hi and R3=CD4luCD8hi B) Comparison of
frequencies of CD4hiCD8loT cells in PBMCs of ACPA+/2 RA, HD and SLE patients. C) Total CD4CD8 DP T cells in ACPA+ (n = 19) and ACPA2 (n = 20) RA
patients. D) Correlation analysis for frequencies of CD4hiCD8lo T cells with age in ACPA+ RA patients. Box plots depict median, interquartile range and
10–90 percentile. Significance as given, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0093293.g001
Double Positive T Cells in RA
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To determine a possible NKT cell phenotype of DP T cells in RA,
we used an antibody recognizing the TCRVa24-Ja18:Vb11,
described for invariant iNKT cells, and a combination of anti-
CD16 together with anti-CD56 to check for non-invariant NKT
cells. The frequency of iNKT cells was not significantly increased
in the DP fraction (0.59%60.13) when compared to CD4 SP or
CD8 SP cells (0.31% vs. 0.32%) (figure 2D). Frequencies of CD16+
cells were low but were significantly increased in DP T cells
(4.8%61.1) when compared to CD4 SP cells (figure 2D). Co-
staining of CD56 and CD16 on DP T cells revealed the presence
of some infrequent (2.4%60.47) CD16+CD56+ cells which
possibly fall into the category of non-invariant NKT cells (data
not shown).
To investigate the TCR repertoire used by DP T cells of RA
patients, we performed FACS analysis using 24 different
antibodies recognizing a broad range of TCR BV chains. The
BV usage within DP T cells of 10 RA patients is divers and does
not differ significantly from CD4 SP or CD8 SP. (figure 3A) 5
patients showed a substantial overrepresentation of individual BV
elements (BV2, BV17 and/or BV21.3) (representative examples
given in figure 3B), possibly indicating antigen-driven clonal
expansion.
DP T cells are Present in the Synovial Tissue and Display
Features of T helper Cells
The target organ in rheumatoid arthritis is the synovium.
Therefore we were interested in identifying DP T cells in the
synovium of inflamed joints. As demonstrated in figure 4A we do
find CD4CD8 double positive T cells (pregated on CD3+ T cells)
in the synovium (mean: 2.5%). Of note, the same RA patients also
showed CD19+ B cells in the synovium (figure 3A).
To explore the potential of CD4CD8 DP T cells to provide B
cell help, the CXCR5 expression was analyzed, since this
chemokine receptor has been described to be present on several
subpopulation of T follicular helper (Tfh) cells, although with
varying support for antibody secretion [20]. The results showed
that DP T cells from RA patients can express CXCR5, although
the fraction of CXCR5 positive cells is higher in CD4 SP than in
CD4CD8DP cells (mean: 9.5% vs. 4.1.%, p = 0.03, figure 4B).
Figure 2. Phenotypic characterization of CD4CD8 DP T cells in RA patients. PBMC from RA patients were isolated and FACS analyses from
live cells were performed (PI staining used for exclusion of dead cells). CD3 pregated cells were further gated on CD4 single, CD8 single and on
CD4CD8 double positive T cells. A) Distribution of CD45RO2CCR7+ (naive) CD45RO+CCR72 (effector memory) and CD45RO+CCR7+ (central memory)
cells in the cell populations indicated. n = 5 5 B) Percentage of T cells positive for CD38 (n = 10) and HLA-DR (n = 11). C) Percentage of cells bearing a
TCR alpha-beta (n = 10) and cells positive for CD8b (n = 9) in the T cell populations indicated. (D) Percentage of cells positive for CD16 (n = 10), CD56
(n = 15) and for TCRVa24-Ja18 (n = 11, marker for iNKT) in the T cell populations indicated. In all graphs, lines represent means and SEM. Significance
as given, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0093293.g002
Double Positive T Cells in RA
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Similar frequencies were found in DP T cells from healthy
individuals (mean 5.1%, data not shown).
As functional and possibly more specific markers of Tfh cells,
the ability to secrete IL-4 and IL-21 following restimulation
in vitro was determined, since both cytokines are required for B
cell help [20,21]. Determination of IL-4 secretion of DP T cells
upon in vitro short term restimulation with Cytostim showed a
substantial fraction of them to produce IL-4 (figure 4C). Impor-
tantly, this percentage of IL-4 producers was significantly higher in
RA patients than in healthy controls (mean: 1.99% vs. 0.71%,
p = 0.0006).
Most importantly, however, a large fraction of DP cells (15–
19%) was found to produce IL-21, compared to only 2% of CD4
SP T cells (figure 4D). No difference between the IL-21 production
of DP T cells from healthy donors compared to those from RA
patients was detectable (figure 4D).
DP T cells in RA Preferentially Produce IFNc but not IL-17
Several abnormal T cell subpopulations are pathogenetically
relevant in RA, among them Th17 cells and IFNc producers [22–
24]. Using cytokine secretion assays as well as intracellular FACS
analysis, IFNc and IL17 expression was determined in vitro after
short term restimulation with the MHC-TCR crosslinker Cytostim
(IFNc) or with PMA/Ionomycin (IL-17). Frequencies of cytokine
producers were calculated as percentage of total CD4CD8 DP T
cells, since cytokine expression was not restricted to a particular
subpopulation (CD4hiCD8lo or CD4luCD8hi) of DP T cells.
In RA patients, significantly more DP T cells produced IFNc
than CD4 SP or CD8 SP T cells (mean 21.1% vs. 3.9% or 12.7%,
p = 0.0001 and p = 0.012, respectively) (figure 5A). In HD, in
contrast, there was no significant difference in the percentage of
IFNc producers between the 3 different T cell populations (CD4
or CD8 SP and DP T cells, data not shown). Most importantly, the
frequency of IFNc producing DP T cells in RA patients
significantly exceeds the frequency found in HD (11.4%)
(figure 5A).
Results for IL-17 were less conclusive. IL-17 was mainly
produced by CD4 SP T cells, and not by CD8 SP or DP positive T
cells (figure 5B). Nevertheless, a trend towards higher IL-17
production was seen in CD4 SP T cells from RA patients
compared to CD4 SP from HD T cells (figure 5B).
Figure 3. TCR BV distribution in CD4CD8 double positive T cells of RA patients. PBMC from RA patients were isolated and FACS analyses
from live cells were performed (PI staining used for exclusion of dead cells). CD3 pre-gated cells were further gated on CD4 single, CD8 single and on
CD4CD8 double positive T cells. Bar charts depict the percentage of cells positive for each BV element in the indicated T cell subpopulations
investigated. A)Mean distribution of 24 TCR BV elements in peripheral blood T cells from 10 RA patients. B) Examples of the individual distribution of
24 TCR BV elements in 4 RA patients.
doi:10.1371/journal.pone.0093293.g003
Double Positive T Cells in RA
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DP T cells are more Frequent in Latent CMV Infection and
Correlate with the Occurrence of CMV Specific Cytokine
Producers
Latent CMV infection in rheumatoid arthritis is associated with
a more severe cause of joint destruction, as published recently by
our group and others [1,17]. This association was limited to ACPA
positive RA. Based on the observed increase of DP T cells in
ACPA positive RA, which are readily able to produce IFNc in
response to polyclonal stimuli, we decided to stratify the patients
according to the presence or absence of anti-CMV IgG antibodies
in the serum. The results showed significantly higher frequencies
of CD4hiCD8lo DP positive T cells, in anti-CMV IgG positive RA
patients compared to CMV2 patients (mean 1.81% vs 0.71%,
p = 0.007, figure 6A). This difference remained significant, if the
analysis was restricted to ACPA positive patients only (mean
2.27% vs. 1.55%, p = 0.039). Interestingly, the highest frequencies
of CD4CD8 DP T cells (mean%: 2.27) were found in patients
simultaneously positive for anti-CMV IgG and ACPA (data not
shown).
CD4+CD28null T cells are increased in RA patients and
associated with a more severe course of the disease [13,25]. In
addition, they are known to occur in the course of a latent CMV
infection both in RA patients and in healthy controls. Therefore,
the frequency of CD4+CD28nullT cells was determined in the RA
patients and found to correlated with the percentages of total
CD4CD8 DP T cells (figure 6B). This correlation was restricted to
ACPA+ RA patients and was not present in ACPA negative
patients. Furthermore, DP T cells were found to preferentially
have lost CD28 expression (mean%: 19,4, n = 13) in ACPA
positive RA patients when compared to CD4 SP (mean%: 1.97) T
cells, while the frequency of CD28 negative cells was even higher
in CD8 SP (mean%: 33) T cells (figure 6B).
Finally, in order to investigate the CMV response, we
restimulated (4 hrs) PBMC from anti-CMV IgG seropositive RA
patients with CMV lysate or control lysate and determined the
CMV specific IFNc production of CD4 SP T cells and CD4CD8
DP T cells by cytokine secretion assay. The frequency of CMV
specific IFNc producers was found to correlate with the
frequencies of total CD4CD8 DP T cells in CMV+ RA patients
Figure 4. CD4CD8 double positive T cells are present in the synovium of RA patients and produce T helper 2 like cytokines. A) Single
cell suspensions were prepared from synovial biopsies from RA patients (n = 4) and analyzed by flow cytometry using anti-CD19, anti-CD3, anti-CD4
and anti-CD8 monoclonal antibodies (PI staining used for exclusion of dead cells). Representative FACS plots are depicted. Each data point represents
one experiment. B) PBMCs from RA patients (n = 6) were isolated and FACS analysis from live cells were performed (PI staining used for exclusion of
dead cells). Cells were pre-gated on CD3+ T cells, and CXCR5 expression was analyzed in the subpopulation indicated. C) PBMC were stimulated
in vitro for 4 hrs with Cytostim. Subsequently, an IL-4 specific secretion assay was performed, and expression of CD4 and CD8 was determined in vital
cells (PI staining used for exclusion of dead cells) pre-gated on CD3. Percentage of IL-4 producing CD4CD8 double positive T cells in HD (n= 7) and RA
patients (n = 8) is given. D) PBMCs from HD (n= 4) and RA (n = 4) were stimulated with PMA/Iono for 4 hrs, and intracellular staining for IL-21 was
performed. Cells are counterstained with anti-CD3, anti-CD4 and anti-CD8. Depicted is the percentage of cytokine producers in total CD4CD8 DP T
cells and in CD4 SP cells. Box plots in C) and D) show median, interquartile range, and 10–90 percentiles. Significance as given, *p,0.05.
doi:10.1371/journal.pone.0093293.g004
Double Positive T Cells in RA
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(figure 6C). Interestingly, the CMV specific IFNc response of
CD4CD8 DP T cells from RA patients was significantly higher
(2.09) than in HD (0.67) (figure 6D). The antigen-induced, CMV
specific proliferation of CD4 SP T cells, in contrast, did not
correlate with the frequency of DP T cells (figure 6E).
Discussion
The study was conducted to investigate a possible role for
peripheral CD4CD8 double positive T cells in the pathogenesis of
rheumatoid arthritis.
The results show, that in RA patients, a significant number of
mature T cells are indeed double positive for both co-receptors,
Figure 5. CD4CD8 double positive T cells from RA patients produce inflammatory IFNc. PBMC from RA and HD were stimulated in vitro
for 4 hrs with Cytostim (A) or PMA/Iono (B). Subsequently, cytokine specific secretion assays (A) or intracellular stainings (B) were performed and cells
were counterstained with anti-CD3, anti-CD4 and anti-CD8. Flow cytometric cytokine analysis were performed on live cells for IFNc secretion (PI
staining used for exclusion of dead cells) or on fixed cells for intra-cellular staining for IL-17, in each case after pre-gating on CD3+ T cells. A)
Percentage of IFNc producing T cells in samples from rheumatoid arthritis patients (n = 12, left panel and grey box in the right panel) and healthy
donors (n = 13, clear box in the right panel) among CD4 SP, CD8 SP and CD4CD8 DP T cells. B) Percentage of IL-17 producing CD4 SP and CD4CD8
double positive T cells from RA patients (n = 4) and HD (n= 4). Presented box plots show median, interquartile range, and 10–90 percentiles.
Significance as given, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0093293.g005
Double Positive T Cells in RA
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CD4 and CD8. Those cells, which can also be found in healthy
individuals – although in significantly lower numbers – preferen-
tially display a memory phenotype, and have been reported to
bear no markers of naı¨ve T cells or recent thymic emigrants [3]
which makes it unlikely that they escaped from the thymus as
double positive cells.
Instead, their co-receptor expression pattern with higher CD4
than CD8 expression, and the fact that CD4hiCD8lo are the most
prominent DP T cell subpopulation, as well as the generally
presumed pivotal role of CD4+ MHC class II restricted T
lymphocytes in RA, suggests that those cells were originally CD4
SP T cells, which gained expression of the second co-receptor
CD8. De novo CD8 expression in CD4+ T cells under the
influence of cytokines like IL-4 has already been described decades
ago [26], but the paucity of IL-4 typically found in RA, makes
such cytokine driven CD8 expression as an explanation for the
emergence of DP T cells in RA less likely. Nevertheless, the
increased IL-4 production of DP T cells in RA may sustain their
CD8 expression in an autocrine manner.
Two new studies published very recently offer an alternative
explanation, since they have identified defined transcription
programs which can initiate CD8 gene expression in CD4 SP T
cells, for example the silencing of the transcription factor Thpok
[27,28] The precise mechanism underlying the emergence of DP
T cells in RA remains to be determined, however.
Increased numbers of double positive T cells were detectable
only in ACPA positive and not in ACPA negative RA patients.
This suggests their involvement in the autoreactive T cell help
provided for auto-reactive, antibody producing B cells in this
disease. In line with this, a fraction of the double positive T cells
was found to express the typical marker of T follicular helper cells,
CXCR5. The percentage of CXCR5 positive cells amongst
double-positive T cells was lower, however, than their percentage
amongst CD4 SP T cells, which argues against a preferential role
of DP T cells as TfH cells. Nevertheless, a proportion of DP T cells
might provide B cell help, especially by their production of
cytokines with a role in T-B cell collaboration, in particular of IL-
21. The site for this B cell help could be non classical follicular
Figure 6. Frequencies of CD4CD8 double positive T cells are increased in CMV positive RA patients and correlate with CMV specific
INFc producers. A) PBMC were isolated from CMV+ RA patients (n = 28) and CMV2 RA patients (n = 12) and analyzed by flow cytometry using anti-
CD19, anti-CD3, anti-CD4 and anti-CD8 monoclonal antibodies (PI staining used for exclusion of dead cells). B) Correlation of the frequency of total
double positive T cells with CD4+CD28null T cells in ACPA+ RA patients (left graph) and comparison of frequencies of CD28null cells among CD4 SP,
CD8 SP and total DP T cells (right graph). C–D) PBMCs were restimulated with CMV-lysate for 4 hrs in vitro. Subsequently, an INFc specific secretion
assay was performed and cells were counterstained with aCD3, aCD4 and aCD8. Flow cytometric cytokine analyses were performed on live cells (PI
staining used for exclusion of dead cells) pre-gated on CD3+ T cells. C) Depicted is the correlation of CMV specific INFc producing CD4 T cells with the
frequencies of CD4CD8 DP cells from the same donor (n = 16). D) CMV specific INFc producing CD4CD8 DP T cells from RA (n= 5) and HD (n= 5) are
shown. E) PBMCs were labeled with CFDA-SE and restimulated with CMV-lysat (n = 13) for 7 d in vitro. Depicted is the correlation of CMV specific CD4
T cell proliferation with the frequencies of CD4CD8 DP cells from the same donor. Presented box plots show median, interquartile range, and 10–90
percentiles. Significance as given, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0093293.g006
Double Positive T Cells in RA
PLOS ONE | www.plosone.org 8 March 2014 | Volume 9 | Issue 3 | e93293
centers, which are found in the synovium of a sizable fraction of
RA patients. [29,30].
RA patients with ACPA positive disease have a more severe
course of the disease with extra-articular manifestations and
increased subclinical arteriosclerosis compared to ACPA- patients
[17]. The increased frequency of CD4CD8 DP T cells in our study
in ACPA positive RA might reflect the more pronounced immune
deviations in those patients and indicates that those cells might be
involved in the destructive immune response in this disease.
Phenotypic characterization of DP T cells in RA reveals them to
be ab T cells of a memory phenotype. Similar characteristics have
been published for DP T cells in healthy donors [3].
NK T cells have received increasing attention in autoimmunity
research recently. DP T cells in RA are not invariant NKT cells,
but a small fraction was positive for markers for non-invariant
NKT cells. This is in contrast to published data [4] for HD and
might indicate a pathogenetically relevant, disease specific role of
DP T cell subpopulations in RA. Furthermore, TCR BV analysis
reveals an overrepresentation of individual BV elements (BV2,
BV17 and/or BV21.3) in DP T cells of some RA patients, possibly
indicating antigen-driven clonal expansion.
DP T cells are present in the rheumatoid synovium. In addition,
our results show that a high percentage of DP T cells have lost
expression of the ubiquitous costimulatory molecule CD28, and
that their frequency is increased in CMV+ RA patients.
CD4+CD28null SP T cells are found in 25–70% of RA patients
and are associated with a more severe course of the disease
[13,25,31]. Recently, we reported CMV+ RA to be associated with
a more severe course of joint destruction [1], and latent CMV
infection is known to lead to an expansion of CD4+CD28null T
cells both in RA patients and in healthy individuals.
The present study showed enhanced frequencies of DP T cells
in CMV+ RA. Recently, we reported an increased CMV specific
IFNc production in RA compared to CMV+ healthy controls. [1]
Furthermore, the frequency of DP T cells in the present study was
found to correlate with the frequency of CD4+ CMV specific IFNc
producers. Interestingly, a low but significant fraction of CD4 SP
T cells, and even higher frequencies of the DP T cells in RA do
produce CMV specific IFNc, more frequently though than T cells
from HD. This is in line with virus specific DP T cells described in
HIV patients [7]. Taken together, those results suggests that DP T
cells are at least in part the results of the same RA specific, CMV
triggered perturbation in the peripheral T cell pool, which also
leads to the occurrence of CD4+CD28null T cells. A CMV specific
enhanced effector response for DP T cells has already been found
in HD [8] and DP T cells are therefore likely also to be involved in
the enhanced CMV response in RA.
Independently of CMV specificity, we found DP T cells to
produce high amounts of IFNc, but no IL-17, upon polyclonal
stimulation. IFNc is a key cytokine driving the autoimmune
response in RA [23,32]. DP T cells in healthy, aging individuals
are known to be capable of producing IFNc upon polyclonal
restimulation [33]. CD28 negative Th cells in RA have also been
shown to secrete IFNc upon autoreactive stimulation, and in line
with this, the DP T cells in RA are also preferentially CD28
negative. Therefore, CD4CD8 DP T cells in RA seem to be part
of the pathological T cell pool characterized by replicative
exhaustion, aberrant IFNc production and phenotypic alterations
including the loss of the ubiquitous co-stimulatory molecule CD28.
DP T cells might be the result of a differentiation program set in
place in terminally differentiated memory Th cells, that is switched
on under conditions associated with immunosenescence, including
the memory inflation observed in latent CMV infection or the
chronic autoimmune response in rheumatoid arthritis.
Conclusion
In summary, we are the first to demonstrate increased
frequencies of peripheral CD4CD8 double positive T cells in
ACPA positive RA.
DP T cells are present in the inflamed synovium. These cells
display features of T helper cells by the production of IL-4 and IL-
21. Furthermore, the production of IFNc, loss of CD28 and the
association with CMV positive RA imply a functional contribution
to the pathogenesis of the disease.
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